Liem T. Nguyen

Liem T. Nguyen serves as a Contracting Officer responsible for managing complex research and development acquisitions across physical, engineering, and life sciences domains. In this role, he ensures compliance with federal acquisition regulations while advancing mission-critical scientific capabilities through competitive, transparent procurement processes. His portfolio primarily involves soliciting and awarding contracts for advanced R&D services, including experimental design, laboratory testing, and analytical system development. Nguyen plays a pivotal role in translating agency scientific priorities into actionable contract requirements, ensuring technical rigor and fiscal accountability throughout the acquisition lifecycle. While no specific contractor relationships are currently identifiable in the data, Nguyen engages with a broad spectrum of vendors, including academic research institutions, private-sector R&D firms, and specialized technical service providers. His procurement approach emphasizes merit-based competition, with a focus on evaluating proposers’ scientific expertise, past performance, and technical feasibility. He maintains a neutral stance toward vendor size or ownership structure, prioritizing capability and compliance over preferred vendor status. Nguyen’s contracting patterns reflect a strong preference for full and open competition, with 100% of his awards issued without set-aside designations. This indicates a deliberate strategy to maximize innovation through broad market access rather than socioeconomic targeting. While he does not routinely utilize 8(a), HUBZone, or SDVOSB set-asides, his approach ensures that all qualified entities—regardless of size or certification—are evaluated on equal footing under merit-based criteria. His primary procurement focus lies in NAICS 541715, 541713, and 541714, covering research and development in physical and engineering sciences, nanotechnology, and biotechnology. He routinely procures services related to materials characterization, molecular modeling, laboratory automation, and clinical trial support. His technical expertise enables him to evaluate complex proposals involving cutting-edge scientific methodologies, ensuring that awarded contracts align with rigorous standards of scientific integrity and innovation.